Tag Archives: prestige journals
What is ONOS’s (real) problem?
The Indian government set the country’s research community aflutter when it announced the launch of a long-awaited plan to improve research access without announcing many of its salient details as well. On November 25, the Ministry of Education published a … Continue reading
Posted in Analysis, Op-eds, Science
Tagged article processing charges, Department of Science & Technology, gold open access, green open access, One Nation One Subscription, prestige journals, Principle Scientific Advisor, publish or perish, scholarly publishing, subscription-based journals
Comments Off on What is ONOS’s (real) problem?
The matter of a journal’s reputation
Apparently (and surprisingly) The Telegraph didn’t allow Dinesh Thakur to respond to an article by Biocon employee Sundar Ramanan, in which Ramanan deems Thakur’s article about the claims to efficacy of the Biocon drug Itolizumab not being backed by enough data to have … Continue reading
Posted in Analysis, Science
Tagged Biocon, Björn Brembs, COVID-19, cytokine release syndrome, Dinesh Thakur, Drug Controller General of India, Itolizumab, Jammi Nagaraj Rao, journal impact factor, Kiran Mazumdar-Shaw, Newslaundry, phase II clinical trials, phase III clinical trials, prestige journals, prestigious journals, reputed journals, Seema Ahuja, Sundar Ramanan, The Telegraph
Comments Off on The matter of a journal’s reputation
The cycle
Is it just me or does everyone see a self-fulfilling prophecy here? For a long time, and assisted ably by the ‘publish or perish’ paradigm, researchers sought to have their papers published in high-impact-factor journals – a.k.a. prestige journals – … Continue reading
Posted in Science
Tagged for-profit publishing, impact factor, Nature journal, peer review, prestige bias, prestige journals, publish or perish, scientific publishing
Comments Off on The cycle